Skip to main content
lexblog.com/lib/703X6RE5viewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Causation Split: First Circuit Pauses Teva Appeal; Regeneron Appeal Going Forward",
    "url": "https://www.lexblog.com/2024/06/21/causation-split-first-circuit-teva-regeneron-appeal/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-703X6RE5",
        "url": "https://www.lexblog.com/lib/703X6RE5/"
    },
    "datePublished": "2024-06-21T12:40:29-04:00",
    "dateModified": "2024-06-21T09:40:55-04:00",
    "author": {
        "@type": "Person",
        "name": "Brian Irving"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Bass, Berry & Sims PLC"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Inside the False Claims Act",
    "about": "Government and Public Policy",
    "sourceUrl": "https://www.insidethefalseclaimsact.com/?p=4095",
    "sourceStability": "may-move"
}